Olga Bartov
Family · Stuart, FLNPI 1417618125
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. 2024 is the largest year on record at $919, 8.4 times the $109 reported in 2022.
Across 92 payments — averaging $19.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$263
- Novartis$219
- Pfizer$160
- Eisai Inc.$148
- Acadia Pharmaceuticals Inc$130
- Kyowa Kirin, Inc.$126
- plus $749 from 16 others
What the payments were for
- Food & beverage$1,795100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $263 |
| Novartis | 20 | $219 |
| Pfizer | 8 | $160 |
| Eisai Inc. | 2 | $148 |
| Acadia Pharmaceuticals Inc | 7 | $130 |
| Kyowa Kirin, Inc. | 5 | $126 |
| AstraZeneca(2 entities) | 6 | $115 |
| UCB, Inc. | 4 | $102 |
| GE HealthCare | 3 | $67 |
| Teva Pharmaceuticals USA, Inc. | 3 | $64 |
| Neurocrine Biosciences, Inc. | 3 | $57 |
| Amgen(2 entities) | 2 | $50 |
| Tanabe Pharma America, Inc. | 2 | $49 |
| Biogen | 2 | $40 |
| Amneal Pharmaceuticals LLC | 2 | $35 |
| Adaptive Biotechnologies Corporation | 1 | $33 |
| Acorda Therapeutics, Inc | 1 | $29 |
| CSL Behring | 1 | $27 |
| MDD US Operations, LLC | 1 | $25 |
| Mylan Institutional Inc. | 1 | $22 |
| Myriad Genetic Laboratories, Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Leqembi$124
How this compares
$1,795 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 14 | $109,490 |
| Duloxetine Hcl | 46 | $1,392 |
| Gabapentin | 78 | $1,264 |
| Memantine Hcl | 39 | $738 |
| Ropinirole Hcl | 33 | $640 |
| Donepezil Hcl | 46 | $639 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 55 | $558 |
| Propranolol Hcl | 12 | $551 |
| Pregabalin | 23 | $480 |
| Baclofen | 17 | $350 |
| Sumatriptan Succinate | 24 | $292 |
| Primidone | 30 | $264 |
| Quetiapine Fumarate | 26 | $264 |
| Topiramate | 17 | $99 |
Paid to pharmacies, not to this prescriber.
Other family in Stuart
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.